3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow MTBVAC: new trials by email Literature Review of MTBVAC trials Research Report on MTBVAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates MTBVAC, BCG - Tuberculosis | Phase 2 | Completed | Biofabri, S.L | 99 | 2019-02-12 | 2025-04-27 |
| MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa MTBVAC, BCG - Tuberculosis | Phase 1 / Phase 2 | Completed | International AIDS Vaccine Initiative | 144 | 2018-05-14 | 2023-02-27 |
| Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults MTBVAC, BCG - Tuberculosis | Phase 1 / Phase 2 | Completed | Biofabri, S.L | 54 | 2015-09-01 | 2018-05-01 |
Tuberculosis (3)
Biofabri, S.L (2) · International AIDS Vaccine Initiative (1)
South Africa (3)
Michele Tameris, MD (2) · Angelique Luabeya, MD (1)